Order book strong, but execution delays and 57% YoY revenue collapse raise near-term concerns
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Reaffirmed 20–25% FY27 growth despite Q1–Q2 YoY decline of 56.7%. Frame is 'lumpy business'—defensible, but execution risk is high.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Order book visibility is real (₹2.7 Cr) and long-term TAM is genuine, but Q2's 57% revenue collapse and manifest execution delays on government contracts expose the gap between stated FY27 guidance (20–25% growth) and near-term delivery. Management has ₹150–200 Cr capex plans against ~₹500 Cr cash, leaving little margin for further shocks.
₹133.3 Cr
Revenue · −56.7% YoY₹21.8 Cr
Reported PAT · −55.6% YoYFlat
Margins · vs guidance: OverstatedDid the claims hold up?
Order inflows during H1 FY27 ₹1,046 Cr including ₹929 Cr in Q2
METQ2 delivered revenue only ₹133.3 Cr, suggesting massive order-to-execution lag
Remaining confident about 20–25% FY27 revenue growth
OVERSTATEDH1 YoY revenue down 56.7%; H2 would need ~38% growth to achieve 20% FY27 target — achievable only if large orders execute
Order book ₹2,698 Cr as of 30-Sep-2026 provides healthy visibility
PartialOrder book visible but ₹956 Cr still negotiated/awaiting formal receipt; execution risk high due to stated delays in approvals
EBITDA margins 35–40% maintained
UnverifiedOPM 23.5%, NPM 15.4% — no EBITDA breakdown given, but operating margin below guidance range
Earnings quality
What changed since the last call
Order inflow acceleration
UpgradeH1 FY27 ₹1,046 Cr inflows vs ₹167 Cr in Q1 FY26 (comparable quarter). Confidence in customer pipeline cited.
Revenue execution timing slippage
DowngradeQ2 FY27 ₹133.3 Cr vs ₹306 Cr Q2 FY26 (-56.7%). Management notes large FY26 Q2 contract executed; current backlog requires H2 ramp to meet FY27 guidance.
Capex guidance reaffirmed
Neutral₹150–200 Cr over 2 years for capacity & R&D. No change to prior call, but intensity rising (new facility, satellite infrastructure).
Product portfolio expansion
NewST Advanced Composites 100% acquisition (Sep 2026) adds composite design capability for radars; satellite development initiated in-house.
The Q&A
Analysts pressed hard on revenue execution gap. Abhijeet Singh (Systematix) asked if revenue guidance at risk; management deflected to 'program-based business' and 'next 1–2 months' order closures. Dipen Vakil (PhillipCapital) asked on HAL pipeline—management vague on Tejas Mk2 (under negotiation, not in projections). Ayush Sharma (Nirmal Bang) asked if 50% of ₹1.7 Cr order book executable by FY27—management agreed this is working estimate but qualified with timing risk on government approvals. Overall tone was managed but defensive.
Negotiated order delays — Abhijeet Singh, Systematix
PartialNo cancellation risk. Central Govt tenders, funded programs. Delays due to internal approval processes (reference/compliance). Expected closure 1–2 months.
FY27 growth feasibility — Abhijeet Singh, Systematix
DodgedYes. This is a quarterly heavy business; we aim for quarterly variation. Orders in hand; will accelerate in H2.
Space segment strategy — Amit Dixit, Goldman Sachs
AnsweredHeavily invested. Counter-drone 1–2 months from demo-ready. Space (satellite) will launch in 3–4 years. Building in-house; not outsourcing.
Export market opportunity — Amit Dixit, Goldman Sachs
PartialPAR (passive radar) for Europe delivery expected Q1 FY28. Co-investing in radars with UK partner. Civil aviation & avionics products also in target. Expect 'large revenue post-qualification' but timeline uncertain.
Space segment timing — Garvit Goyal, Serene Alpha
DodgedMk2 is not anti-drone. Tejas Mk2 under negotiation with HAL (should close in next couple of months). Not part of projections yet. Many other products (pod, AMCA) can be positioned in Mk2 also.
5-year order scaling potential — Sagar Gandhi, Invesco Mutual Fund
PartialProducts we design can scale 5x the current numbers. Risk is in development—we're reducing via building blocks model. India's 0 base in defence products means no precedent. Scaling is achievable if we build competencies.
Capex spend on capabilities — Keyurkumar Vadaliya, Niveshaay
PartialBuilding blocks are customizable for any product/market. ₹150 Cr is multi-purpose capacity & facility. Additional investment (>₹150 Cr) also planned for infrastructure & satellite manufacturing. Board approval pending.
BrahMos seeker manufacturing — Akshay Jogani, Xponent Tribe
AnsweredSeeker undergoing qualification test. Only post-qualification will production orders come. Expect production orders in next few months; manufacturing line setup underway.
Order execution sequencing — Neil Ostwal, PGIM India
AnsweredSome execute this year. Some next year & year after. Scheduled delivery timelines given by customer; we will confirm. 20–25% growth plan assumes execution over 2 quarters to achieve guidance.
Order book execution expectation — Ayush Sharma, Nirmal Bang
AnsweredSomewhere around 50% in next 2 quarters to achieve guidance. Depends on customer delivery schedules & approvals. Some delays in existing programs; components already ordered; prudent in timelines.
Counter-drone tender participation — Abhijeet Singh, Systematix
PartialHawk—still delays in software integration but hardware ready. Sukhoi-30 pods self-protection jammer progressing well. Air Force happy. Expect integration in next months. Counter-drone tenders—already participating on Make II programs; product complete.
Guidance
FY27 revenue growth 20–25%
MediumReaffirmed despite H1 YoY decline of 56.7%. Contingent on H2 acceleration & order-to-revenue conversion from ₹1.7 Cr order book.
EBITDA margins 35–40%
MediumOPM 23.5%, NPM 15.4% reported; EBITDA breakdown not disclosed. Heavy capex & R&D drag margins in near-term.
₹150–200 Cr capex over 2 years
MediumSplit between capability building, facilities, satellite manufacturing infrastructure. Additional investment (>₹150 Cr) also planned post-Board approval.
Risks the call surfaced
Order execution timing
High₹956 Cr negotiated orders stuck in government approval processes. CFO: 'The delay is on account of internal processes... different approval processes.' Q2 order inflows (₹929 Cr) have not yet converted to revenue.
FY27 guidance at risk
HighH1 FY27 YoY revenue decline 56.7% (₹133.3 Cr Q2, ₹116 Cr Q1). To achieve 20% FY27 growth, H2 must grow ~38% YoY. Achievable only if large orders execute.
New product development risk
HighSatellite, anti-drones, Tejas Mk2, BrahMos seeker all in early stages. Satellite 3–4 years away; counter-drone tenders uncertain; BrahMos seeker still in qualification test. No near-term revenue.
Customer concentration & market dependency
MediumDominant customer base is DRDO, PSU (Bharat Electronics, HAL). Government budget allocation, approval delays, tender process cycles dictate order flow. Private sector expansion nascent.
Capex intensity & liquidity squeeze
Medium₹150–200 Cr capex over 2 years planned; cash balance >₹500 Cr. Additional investment (>₹150 Cr) also discussed post-Board approval. If new orders don't convert to cash, liquidity could tighten.
Management
Score 6/10. Detailed on product roadmap & strategic vision but evasive on sensitive export/space programs. Transparent on order book & cash, but minimizes execution risk. Track record mixed: delivered large FY26 Q2 contract but missed near-term guidance in H1 FY27 (56.7% YoY decline). Order conversion bottleneck evident despite healthy pipeline.
1 · Nov 2026 – Feb 2027
₹956 Cr negotiated orders expected to close for formal receipt
2 · H2 FY27 (Jan–Mar 2027)
Program deliveries expected to accelerate; counter-drone tender bids and Make II participations
3 · FY28
BrahMos seeker production orders post-qualification; PAR radar exports expected Q1 FY28 delivery
Management has ₹150–200 Cr capex plans against ~₹500 Cr cash, leaving little margin for further shocks.
Informational and educational content only. Not investment advice.